Resumo

AGUILERA-CASTRO, Lara; MARTIN-DE-ARGILA-DE-PRADOS, Carlos  e  ALBILLOS-MARTINEZ, Agustín. Practical considerations in the management of proton-pump inhibitors. Rev. esp. enferm. dig. [online]. 2016, vol.108, n.3, pp.145-153. ISSN 1130-0108.

Proton-pump inhibitors (PPIs) are one of the most active ingredients prescribed in Spain. In recent decades there has been an overuse of these drugs in both outpatient clinics and hospitals that has lead to a significant increase in healthcare spending and to an increase in the risk of possible side effects. It is important for health professionals to know the accepted indications and the correct doses for the use of these drugs. On the market there are different types of PPI: omeprazole, pantoprazole, lansoprazole, rabeprazole and esomeprazole. Omeprazole is the oldest and most used PPI, being also the cheapest. Although there are no important differences between PPIs in curing diseases, esomeprazole, a new-generation PPI, has proved to be more effective in eradicating H. pylori and in healing severe esophagitis compared to other PPIs. In recent years the use of generic drugs has spread; these drugs have the same bioavailability than the original drugs. In the case of PPIs, the few comparative studies available in the literature between original and generic drugs have shown no significant differences in clinical efficacy.

Palavras-chave : Proton-pump inhibitor; PPI; Omeprazole; Pantoprazole; Lansoprazole; Rabeprazole; Esomeprazole.

        · resumo em Espanhol     · texto em Inglês | Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )